Relmada Therapeutics, Inc. · NASDAQ:RLMD
Relmada Therapeutics, Inc. shareholders
As of Sep 30, 2026, 131 institutions reported holding Relmada Therapeutics, Inc., 97.8% of its shares. Largest: Janus Henderson, BlackRock and Venrock Adviser, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Relmada Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Janus Henderson | 11.2M | 10.5% | first report | Nov 16, 2026 |
| BlackRock | 7.58M | 7.1% | +150K | Nov 13, 2026 |
| Venrock Adviser, LLC | 7.45M | 7.0% | +601K | Nov 16, 2026 |
| Spruce Street Capital LP | 6.91M | 6.5% | +521K | Nov 13, 2026 |
| Vanguard | 6.27M | 5.9% | +131K | Nov 13, 2026 |
| Jones Hill Capital LP | 5.24M | 4.9% | +1.58M | Nov 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 4.76M | 4.5% | no change | Nov 16, 2026 |
| Ameriprise | 3.72M | 3.5% | +1.78M | Nov 16, 2026 |
| Sio Capital Management, LLC | 3.63M | 3.4% | +2.63M | Nov 16, 2026 |
| Squadron Capital Management LLC | 3.5M | 3.3% | −3.85M | Nov 16, 2026 |